Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by TeddyTenBagson May 27, 2021 8:48am
168 Views
Post# 33274286

RE:RE:RE:Squeeze

RE:RE:RE:SqueezeLololol ya those 2M shares that represent less than a percent of total share count are really going to cover that massive short interest that's out there. Keep spewing false information because you're a bag holder.

Superss63 wrote: Yeah & those 2 million shares bought at the end of that day that made the price pop about 65 cents was just some guys that had a woody for the stock & nothing to do with the covering of shorts. A short squeeze doesn't have to be prolonged, it could be a settling of accounts & that's exactly what that smelled like. 

TeddyTenBags wrote: There's no squeeze coming. Not now. Not any time soon. This stock has hardly been shorted, yet people keep posting about this hoping to get people to buy in for some GME type of run, which ain't happening. 

Superss63 wrote: Might see a squeeze here. 

 




<< Previous
Bullboard Posts
Next >>